van der Pluijm, Rob W <br/><br/>
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.  [electronic resource] 

 -  The Lancet. Infectious diseases  09 2019 
 - 952-961 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(19)30391-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antimalarials--therapeutic use<br/>Artemisinins--therapeutic use<br/>Cambodia<br/>Drug Resistance, Multiple--genetics<br/>Drug Therapy, Combination<br/>Female<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Malaria, Falciparum--drug therapy<br/>Male<br/>Mefloquine--therapeutic use<br/>Membrane Transport Proteins--genetics<br/>Middle Aged<br/>Mutation<br/>Plasmodium falciparum--drug effects<br/>Prospective Studies<br/>Protozoan Proteins--genetics<br/>Quinolines--therapeutic use<br/>Thailand<br/>Treatment Failure<br/>Vietnam<br/>Young Adult